Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Instagram
Elon Musk
Sergey Brin
Artificial Intelligence and Machine Learning
OnePlus 10T
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Technology News / Bharat Biotech signs deal for nasal COVID-19 vaccine: Details here
Technology

Bharat Biotech signs deal for nasal COVID-19 vaccine: Details here

Bharat Biotech signs deal for nasal COVID-19 vaccine: Details here
Written by Shubham Sharma
Sep 23, 2020, 02:44 pm 3 min read
Bharat Biotech signs deal for nasal COVID-19 vaccine: Details here

In a major move, Bharat Biotech has signed an agreement to license a nasal COVID-19 vaccine developed by the Washington University School of Medicine in St. Louis, United States. The agreement will see the Indian biotech firm manufacture and distribute the novel solution for the deadly respiratory disease across several countries, including our own. Here is all you need to know about the agreement.

Deal
What does the agreement entail?

Under the deal, announced just recently, Bharat Biotech and US-based biotech firm Precision Virologics acquired rights to WUSM's chimp-adenovirus intra-nasal vaccine for COVID-19. The US firm has access to the vaccine technology for supply in the US, Europe, and Japan, while the Indian company will be handling distribution in all other markets, starting with India.

Details
Bharat Biotech will conduct clinical trials in India

The single dose nasal vaccine has already shown "unprecedented levels of protection in mouse studies" and is cleared for a Phase-1 human trial, which will be conducted at Saint Louis University's Vaccine and Treatment Evaluation Unit. The advanced phases of the clinical study will be carried out in India upon receiving necessary approvals from the Drugs Controller General of India.

Manufacturing
Manufacturing at company's India facility

Along with trials, Bharat Biotech will also be undertaking large-scale manufacturing of the vaccine at its GMP facility in Genome Valley, Hyderabad. "We are proud to collaborate on this innovative vaccine," said Dr. Krishna Ella, the Chairman and MD of Bharat Biotech. "We envision that we will scale this vaccine to 1 billion doses, translating to 1 billion individuals vaccinated receiving a single-dose regimen."

Advantage
Nasal vaccine expected to be more effective, easier to administer

A single dose nasal vaccine will be easier to administer, which will enable a broader reach while reducing the cost of medical consumables such as syringes. Precision Virologics Interim CEO David T. Curiel says that "it also prevents the spread of the disease by directly targeting the cells that line the nose and throat. Most other vaccine candidates currently under development can't do that."

COVAXIN
Bharat Biotech is also making its own homegrown COVID-19 vaccine

The licensing agreement comes as Bharat Biotech continues to work on its own, homegrown COVID-19 vaccine dubbed COVAXIN. The shot has been proven safe and effective in pre-clinical animal trials, and now, it is moving through the Phase-2 of human trials at multiple sites. The third phase is slated to begin sometime next month, according to recent reports.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Shubham Sharma
Shubham Sharma
Twitter
Editor with over five years of experience in covering all things science, consumer tech, space tech, AI, infosec, and business. A commerce graduate from University of Lucknow. I have been handling Tech beat at NewsBytes since 2018.
Latest
Europe
United States of America
Washington University
Drugs Controller General of India
Coronavirus
Related
Latest
'Ek Villain Returns' to 'Vikrant Rona': Examining box office collections
'Ek Villain Returns' to 'Vikrant Rona': Examining box office collections Entertainment
Gary Ballance could quit England cricket to play for Zimbabwe
Gary Ballance could quit England cricket to play for Zimbabwe Sports
OnePlus 10T launched in India at Rs. 50,000: Check specifications
OnePlus 10T launched in India at Rs. 50,000: Check specifications Technology
Commonwealth Games: Indian men's hockey team blanks Canada 8-0
Commonwealth Games: Indian men's hockey team blanks Canada 8-0 Sports
Aamir made changes to 'LSC' after South stars' special screening?
Aamir made changes to 'LSC' after South stars' special screening? Entertainment
Europe
Know everything about International Chess Day 2022
Know everything about International Chess Day 2022 Lifestyle
World Emoji Day: How emojis are changing world of expression
World Emoji Day: How emojis are changing world of expression Lifestyle
Visiting Denmark? Check out these amazing national parks
Visiting Denmark? Check out these amazing national parks Lifestyle
Traveling to Europe on a budget? Explore the Balkans
Traveling to Europe on a budget? Explore the Balkans Lifestyle
5 national parks to visit in Greece
5 national parks to visit in Greece Lifestyle
More News
United States of America
Nancy Pelosi in Taiwan: Addresses Taiwan Parliament; China enraged
Nancy Pelosi in Taiwan: Addresses Taiwan Parliament; China enraged World
US House Speaker Nancy Pelosi reaches Taiwan amid China's warnings
US House Speaker Nancy Pelosi reaches Taiwan amid China's warnings World
Who was al-Zawahiri, al-Qaeda chief killed in US drone strike?
Who was al-Zawahiri, al-Qaeda chief killed in US drone strike? World
US kills al-Qaeda chief Ayman al-Zawahiri in drone strike
US kills al-Qaeda chief Ayman al-Zawahiri in drone strike World
Biden tests positive for COVID-19; rare case of 'rebound positivity'
Biden tests positive for COVID-19; rare case of 'rebound positivity' World
More News
Washington University
India to play crucial role in COVID-19 vaccine process
India to play crucial role in COVID-19 vaccine process Technology
Nobel Prize: Three scientists win for 'discovering Hepatitis C virus'
Nobel Prize: Three scientists win for 'discovering Hepatitis C virus' Technology
Experts think first COVID-19 vaccines might not prevent infection
Experts think first COVID-19 vaccines might not prevent infection World
This neurosurgeon wants to connect humans with Internet using brain-implants!
This neurosurgeon wants to connect humans with Internet using brain-implants! Technology
Trump reluctant to honour election's outcome
Trump reluctant to honour election's outcome World
More News
Drugs Controller General of India
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
Biological E's Corbevax vaccine approved for children aged 12-18 years
Biological E's Corbevax vaccine approved for children aged 12-18 years India
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
More News
Coronavirus
How long does immunity last after COVID-19?
How long does immunity last after COVID-19? Technology
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming India
COVID-19: India logs 7,584 fresh cases, 24 more fatalities
COVID-19: India logs 7,584 fresh cases, 24 more fatalities India
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
More News
Related
COVAXIN supply to be increased as teens get COVID-19 vaccines
COVAXIN supply to be increased as teens get COVID-19 vaccines India
Next News Article
Next News Article

Love Technology news?

Subscribe to stay updated.

Science Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022